GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.
Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
3.35%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
58
Reduced
29
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$23.9M |
| 2 |
2
Loomis, Sayles & Company
Boston,
Massachusetts
|
$20.9M |
| 3 |
NI
3
Numeric Investors
Boston,
Massachusetts
|
$5.55M |
| 4 |
4
Morgan Stanley
New York
|
$4.35M |
| 5 |
5
Goldman Sachs
New York
|
$14.4M |
